Who is sponsoring NCT05128747?

NCT05128747 is sponsored by Assiut University.

What drugs are being tested in NCT05128747?

Interventions in NCT05128747: DASH diet.

What condition does NCT05128747 study?

NCT05128747 studies Dyslipidemia Associated With Type II Diabetes Mellitus.

Is NCT05128747 still recruiting?

NCT05128747 is currently status unknown. Last updated 22 November 2021.

Last reviewed 2021-11-22 · How we verify

NCT05128747

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Nutritional Program Among Diabetic Patients

Status unknown NA Last updated 22 November 2021

What this trial tests

NA trial testing DASH diet in Dyslipidemia Associated With Type II Diabetes Mellitus in 190 participants. Status unknown.

Timeline

1 March 2022

Primary endpoint
1 October 2022

30 December 2022

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	190
Start date	1 March 2022
Primary completion	1 October 2022
Estimated completion	30 December 2022

Drugs / interventions tested

DASH diet

Conditions studied

Dyslipidemia Associated With Type II Diabetes Mellitus — all drugs for Dyslipidemia Associated With Type II Diabetes Mellitus →

Sponsor

Assiut University

Who can join

Adults 30 to 70, any sex, with Dyslipidemia Associated With Type II Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dyslipidemia is very common in type 2 diabetes mellitus affecting around 72%-85% of diabetic patients.The exact mechanism of lipoprotein abnormalities in diabetes is not very well understood. Insulin resistance, rather than hyperglycemia, has been implicated in the pathogenesis of diabetic dyslipidemia because lipoprotein changes including an increase in triglycerides (TG), increase in VLDL particles, small dense LDL particles and a decrease in HDL level have been shown in patients with impaired fasting glucose and impaired glucose tolerance and T2DM

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of DASH diet

Trials testing the same drug.

NCT07188272 — Effect of High-intensity Interval Training Combined With DASH Diet on Arterial Stiffness in Hypertensive Patients · NA · completed
NCT06978504 — Impact of Genetic Polymorphisms And DASH Diet On Weight Loss Progression In Climacteric Women With Metabolic Syndrome · NA · recruiting
NCT06499194 — Health Expenses and Outcomes of the DASH Diet in Egyptian Patients With Hypertension · NA · completed
NCT05533268 — Effect of Mental and Physical Training on Blood Pressure · NA · completed
NCT05452642 — The Supporting Understanding of PCOS Education and Research (SUPER) Study · NA · active not recruiting

Other recruiting trials for Dyslipidemia Associated With Type II Diabetes Mellitus

Currently open trials in the same condition.

NCT07359105 — Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-El · NA · recruiting
NCT04943926 — Dietary Strategies for Remission of Type 2 Diabetes · NA · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05128747 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 22 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05128747.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing